• Evaluation of Injectable Lanreotide Acetate in The Treatment of Liver Carcinoma

    Nov 1, 2016, 00:00

  • Cancer Drugs in The EU5 and USA- Cross-Country Pricing Comparison and Correlation Analysis Between Overall Survival (OS) and Progression-Free Survival (PFS)

    Nov 1, 2016, 00:00

  • A Review of Treatment on Alzheimer's Disease in China

    Nov 1, 2016, 00:00

  • Impact of Adherence on Subcutaneous Interferon Beta-1a Effectiveness Administered by Rebismart® in Patients with Multiple Sclerosis

    Nov 1, 2016, 00:00

  • A Systematic Review and Meta-Analysis on Tolerability and Efficacy of Sofosbuvir Containing Regimens in Hepatitis C Patients With Stage 4-5 Chronic Kidney Disease

    Nov 1, 2016, 00:00

  • The Impact on Access to Innovative Drugs of The First Managed Entry Agreements in Romania

    Nov 1, 2016, 00:00

  • Different Values In Cost-Effectiveness Research- Institute for Clinical and Economic Review (ICER) VS. The National Institute for Care Excellence (NICE)

    Nov 1, 2016, 00:00

  • The Economic Burden of Four Heart Conditions in Mexico

    Nov 1, 2016, 00:00

  • Recent Trends In Different Devices, Operating Systems, And Browsers Used By Patients Taking Part In Online Medical Surveys

    Nov 1, 2016, 00:00

  • A Model-Based Cost-Effectiveness Analysis of B-Type Natriuretic Peptide Monitoring in Patients with Heart Failure

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Combination Therapy with Dutasteride/Tamsulosin- An Analysis Based on Conduct Trial

    Nov 1, 2016, 00:00

  • Prescribing Pattern of Anti Hypertensive Agents in A Tertiary Care Hospital Outpatient Department

    Nov 1, 2016, 00:00

  • The Ethical Issues Of Pharmacogenetic Tests

    Nov 1, 2016, 00:00

  • The Transparency Of Published Recommendations On Reimbursement Of Health Technologies In Poland

    Nov 1, 2016, 00:00

  • Are Component Endpoints Equal? A Study into the Practice of Composite End Points in Clinical Trials

    Nov 1, 2016, 00:00

  • Jointly Modeling Survival and EQ-5D Data to Estimate Health Utilities for Her2+ Metastatic Gastric Cancer

    Nov 1, 2016, 00:00

  • Recommendations for the Calculation of Transition Probabilities in Markov Cohort Models- A Targeted Literature Review

    Nov 1, 2016, 00:00

  • Case Duration As A Surgical Quality And Efficiency Indicator In Surgical Residency Training Programs

    Nov 1, 2016, 00:00

  • Characteristics and Quality of Life in Peripheral Arterial Disease(Pad) Patients In Korea- Results From Pad Outcomes Research

    Nov 1, 2016, 00:00

  • Type 2 Diabetes- How Much Does it Cost During the First 8 Years after the First Antidiabetic Treatment? A Dynamic Approach from the French National Health Insurance

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Pixantrone for the Third-/Fourth-Line Treatment of Aggressive Non-Hodgkin’s Lymphoma in Portugal

    Nov 1, 2016, 00:00

  • HT5 Development of a Multi-Criteria Decision Analysis (MCDA) Framework for Health Care Decision-Making in Catalonia (Spain)- Pilot Study Focused in Orphan Drugs

    Nov 1, 2016, 00:00

  • Adaptive Reimbursement Model- How to Correlate The Price to The Level of Evidences During The Entire Drug Life Cycle

    Nov 1, 2016, 00:00

  • Predicting Patient-Reported Outcomes from Disease-Specific Questionnaires- A Comparison of Seven Methodologies

    Nov 1, 2016, 00:00

  • Evaluating The Economic Burden and Health Care Utilization Of Breast Cancer in The Us Medicare Population

    Nov 1, 2016, 00:00

  • Effects Of Pharmacist Counseling on Outpatients Receiving Warfarin at Dr. Hasan Sadikin Bandung Hospital

    Nov 1, 2016, 00:00

  • Man Versus Machine - Is Accurate Automation of Data Abstraction Achievable?

    Nov 1, 2016, 00:00

  • Italian Timings In New Drugs Approval- An Up-To-Date Analysis

    Nov 1, 2016, 00:00

  • Association Between The Prices Of Orphan Drugs In Oncology And The Patient Population Sizes

    Nov 1, 2016, 00:00

  • Do We Really Know when We Should Screen for Hepatitis B C before Starting Immunosuppressive Therapy ?

    Nov 1, 2016, 00:00

  • A Retrospective Study of Healthcare Costs in Patients with end Stage Lung Cancer During The Last Six Months of their Life

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Diagnostic Tests for People At Risk of Non-Alcoholic Fatty Liver Disease (NAFLD) in The UK

    Nov 1, 2016, 00:00

  • Hba1c Variability Predicts Short-Term Risk of Albuminuria In Patients with Type 2 Diabetes

    Nov 1, 2016, 00:00

  • Development of a Patient-Reported Outcome Measure for Chronic Hypoparathyroidism

    Nov 1, 2016, 00:00

  • Recent Trends in Percutaneous Coronary Intervention Volume in the United States

    Nov 1, 2016, 00:00

  • Upcoming Regulations on Insurance Reimbursement Standard in China- Chanllanges and Opportunites for Mncs

    Nov 1, 2016, 00:00

  • Cost Analysis of Intrathecal Baclofen Therapy For The Treatment of Spastic Cerebral Palsy In The Russian Federation

    Nov 1, 2016, 00:00

  • An Observational Study on Risk Factors and Clinical Presentation S In Stroke Patients

    Nov 1, 2016, 00:00

  • Budget Impact Analysis of Dasatinib in Imatinib-Resistant Or-Intolerant Patients with Chronic Phase Chronic Myeloid Leukemia (Cml-Cp) in the Chinese Setting

    Nov 1, 2016, 00:00

  • Types of Risk-Sharing Schemes Proposed in Reimbursement Application Received by Aotmit in 2015

    Nov 1, 2016, 00:00

  • All-Cause Mortality and Cardiovascular Events After Acute Myocardial Infarction and 12-Months Dual Platelet-Aggregation Inhibition in Clinical Practice. Findings from the Piper Study

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Apixaban for The Treatment of Atrial Fibrillation Patients in The Kingdom of Saudi Arabia

    Nov 1, 2016, 00:00

  • Description of the Impact of Hypertension on Hospitalisations for Cardiovascular Diseases in Japan Using a Japanese Claims Database

    Nov 1, 2016, 00:00

  • Real-World Outcomes of Ipilimumab in Patients with Advanced Melanoma in The Netherlands

    Nov 1, 2016, 00:00

  • what Do we Pay for Compounded Drugs?

    Nov 1, 2016, 00:00

  • The Impact of Duration on EQ‐5D‐5l Value Sets Derived from a Discrete Choice Experiment

    Nov 1, 2016, 00:00

  • A Comprehensive Economic Model for Dementia- Diagnosis, Disease Progression and Service Delivery

    Nov 1, 2016, 00:00

  • Economic Burden of Medical Transports In France over The Year 2014

    Nov 1, 2016, 00:00

  • A Comparison of Long-Term Anticholinergic Burden Derived from Different Risk Scales with Adverse Clinical Outcomes in the Elderly

    Nov 1, 2016, 00:00

  • Drug Utilization Evaluation of Amoxicillin-Clavulanic Acid in Csom Patients in a South Indian Hospital- A Retrospective Analysis

    Nov 1, 2016, 00:00

  • Landscape of Advanced NSCLC- The Impact of Upcoming Therapies

    Nov 1, 2016, 00:00

  • Costs and Clinical Outcomes in The Management of Metastatic Castration-Resistant Prostate Cancer in Greece

    Nov 1, 2016, 00:00

  • Development and Content Validity of the Advanced Systemic Mastocytosis Symptom Assessment Form (ADVSM-SAF)

    Nov 1, 2016, 00:00

  • Network Meta-Analysis of Randomized Trials to Compare the Efficacy of Nsaids, Statins and Vitamins in Alzheimer's Disease

    Nov 1, 2016, 00:00

  • Empirical Calibration of Hepatitis C Virus (HCV) Natural History Model to the Chinese HCV-Infected Population

    Nov 1, 2016, 00:00

  • Cost-Utility Analysis of Lorcaserin In The Treatment of Obesity

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Transfemoral Aortic Valve Implantation Compared with Surgical Aortic Valve and Medical Management in Patients with Severe Symptomatic Aortic Stenosis in Australia

    Nov 1, 2016, 00:00

  • Economic Impact Of Adverse Drug Reactions- A Pubmed Based Study

    Nov 1, 2016, 00:00

  • Economic Burden of Community-Acquired Pneumonia Among Elderly

    Nov 1, 2016, 00:00

  • The Cost of Remaining NTM Positive- Health Care Utilization and Costs In A Sample of Patients with Refractory Pulmonary Disease Due To Mycobacterium Avium Complex In Canada, Germany, United Kingdom And France

    Nov 1, 2016, 00:00

  • An Investigation Into Open-Source Modelling In Health Economics- Opportunities And Challenges

    Nov 1, 2016, 00:00

  • Cost Analysis Of Raltegravir Versus Atazanavir/R Or Darunavir/R For Treatment-Naive Adults With Hiv-1 Infection In Spain

    Nov 1, 2016, 00:00

  • Effect of Drug Cost-Sharing Change on Non-Adherence to Essential Medications for Acute Coronary Syndrome- A Population Based Natural Experiment

    Nov 1, 2016, 00:00

  • A Comparative Analysis on Health Security System Between China and Developed Countries

    Nov 1, 2016, 00:00

  • One-Year Patient-Reported Persistence To Antiresorptive Treatment In A Fracture Liaison Servi The Lucky Bone™ Program

    Nov 1, 2016, 00:00

  • Temperature, Real Time, on Site, Potency Monitoring Studies of Different Brands of Cephalexin Tablets Stored in Hospital and Community Pharmacies in Different Part of Kerala

    Nov 1, 2016, 00:00

  • Towards Better Coordination and More Efficient Patient Pathways in Copd

    Nov 1, 2016, 00:00

  • The Effect of Diabetes on the Quality-of-Life in Community-Dwelling Elderly in The Netherlands

    Nov 1, 2016, 00:00

  • Defining Episodes of Care for Chronic Diseases- A Targeted Literature Review

    Nov 1, 2016, 00:00

  • Budget Impact Analysis of Using Pazopanib-Everolimus in First and Second Line of Treatment, In Patients with Metastatic Renal Cell Carcinoma

    Nov 1, 2016, 00:00

  • Factors Associated with The Mental and Physical Health-Related Quality of Life (HRQOL) of Asthma Patients- A Cross-Sectional Analysis Based On 673 Patients

    Nov 1, 2016, 00:00

  • Economic Evaluation of ASA 100mg, Simvastatin 40mg and Ramipril 5-10mg (POLYPILL) for Secondary Prevention of Cardiovascular Events in Mexico

    Nov 1, 2016, 00:00

  • General Practitioners Perceptions About Financial and Non-Financial Incentives to Improve Influenza Vaccination Coverage Rates In France

    Nov 1, 2016, 00:00

  • Clinical Impact of Antimicrobial Impregnated Catheters For Reduction of Infection In Cerebrospinal Fluid Diversion Procedures

    Nov 1, 2016, 00:00

  • German Travelers’ Preferencences For Vaccines Against Travel-Related Illnesses

    Nov 1, 2016, 00:00

  • The Burden of Inflammatory Bowel Disease(IBD) in Japan

    Nov 1, 2016, 00:00

  • Economic and Humanistic Benefits of Maintaining Cognitive Impairment Patients in the Early Stage

    Nov 1, 2016, 00:00

  • UK Cost-Effectiveness Analysis for Management of CMV Disease in Patients Post Allogeneic Stem Cell Transplantation with a Novel Adoptive T Cell Therapy

    Nov 1, 2016, 00:00

  • Retrospecive Patient Chart Study to Evaluate Real Life Treatment and Event Rate of Patients Surviving Their Myocardial Infarction for at Least 12 Months

    Nov 1, 2016, 00:00

  • Dose Escalation of Biologics in Crohn’s Disease- Summary of Observational Studies in the UK

    Nov 1, 2016, 00:00

  • How Are Fast-Track Programmes Like Rapid Recovery Delivering Value Across Hospitals, Cultures And Healthcare Systems In Orthopedics Within A Cost-Constrained Environment?

    Nov 1, 2016, 00:00

  • Assessing Health-State Utility Values in Australian People with Multiple Sclerosis

    Nov 1, 2016, 00:00

  • ASSESSMENT OF PET/CT USE IN RADIOTHERAPY PLANNING VERSUS CT SCANS USE ONLY

    Nov 1, 2016, 00:00

  • Long-Term Improvements in Workplace and Household Productivity and Social Participation Over 4 Years of Certolizumab Pegol Treatment in Patients with Psoriatic Arthritis, with and without Prior Anti-Tnf Exposure

    Nov 1, 2016, 00:00

  • How To Select The Best Comparator? An International Economic Evaluation Guidelines Comparison

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis Of Laparoscopic Surgery For Presumed Leiomyomas

    Nov 1, 2016, 00:00

  • Effect Of A Pay-For-Performance Program For Diabetes On Health Status (Eq-5d) In Taiwan

    Nov 1, 2016, 00:00

  • Economic Evaluation Guideline for Pharmaceuticals and Medical Devices in Japan

    Nov 1, 2016, 00:00

  • Imatinib Discontinuation and Tki Switching Patterns in the Retrospective and Prospective Cohorts in Simplicity, A Study of Chronic-Phase Chronic Myeloid Leukemia (CP-CML) Patients (PTS) in Routine Clinical Practice

    Nov 1, 2016, 00:00

  • The Patient-Risk of Hypoglycaemia As A Function of Pharmacological Treatments. A Retrospective Analysis on Database Hypothesis

    Nov 1, 2016, 00:00

  • Prompt Value Assessment Of Breakthrough Interventions With Limited Outcome Data

    Nov 1, 2016, 00:00

  • The Benefits of A Holistic View- Considering Multiple Health Outcomes for Hiv and Sti Testing

    Nov 1, 2016, 00:00

  • The Effect of Therapeutic Drug Monitoring in Patients Complian An Improvement in Drug Efficacy and Corresponding Reduction in Toxicity Using Aminoglycosides

    Nov 1, 2016, 00:00

  • The Evolution And Comparison Of Hta Assesment Organisations In Selected European Countries

    Nov 1, 2016, 00:00

  • Comparing Eq-5d-3l And Eq-5d-5l In A General Population

    Nov 1, 2016, 00:00

  • The Economic Burden of Heart Failure in Greece From A Social Security System Perspective

    Nov 1, 2016, 00:00

  • The Determinants Of Innovative Drugs Prices- The Case Of Oncology Drugs, Comparative Analysis

    Nov 1, 2016, 00:00

  • Using Acoustic Simulations of Hearing Loss to Describe Health States- Are they Feasible and Reliable to use?

    Nov 1, 2016, 00:00

  • Investigation Of The Work Ability Of Nurses And Its Influencing Factors

    Nov 1, 2016, 00:00

  • Self-Reported Client Satisfaction In The Primary Care Development Model Programme

    Nov 1, 2016, 00:00

  • Treatment Satisfaction Of Osteoporosis Medication In Postmenopausal Women Of Korea; Results From The Study Of Osteoporosis Medication Adherence And Satisfaction In Postmenopausal Women

    Nov 1, 2016, 00:00

  • Economic and Humanistic Impact Assumptions for Hypoglycemic Events- Implications for Cost-Effectiveness Analyses in Insulin-Treated Diabetes

    Nov 1, 2016, 00:00

  • Quinolones Utilization In Two Tertiary Hospitals In Nigeria; Exploring Drug Use Towards Improved Treatment Outcomes

    Nov 1, 2016, 00:00

  • Public Knowledge and Attitudes Towards Zika Virus and its Prevention in Malaysia

    Nov 1, 2016, 00:00

  • The Effectiveness Analysis of Selected Radiosurgery Devices on Treatment of Cancer Tumors and Arteriovenous Malformations- A Systematic Review

    Nov 1, 2016, 00:00

  • Future Innovative Therapies for Parkinson's Disease May Question Sustainability of Our Health Care System

    Nov 1, 2016, 00:00

  • Pharmaceutical Tracking System- An Improvement in Data Accuracy and Uses

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Of Fingolimod Vs Brace Cycling Followed By A Switch To Fingolimod In Patients Failing Prior Treatment

    Nov 1, 2016, 00:00

  • Overview of the Budget Impact Analysis of Drugs in Hungary and Internationally

    Nov 1, 2016, 00:00

  • Combined use of Administrative Data Flows with Innovative Biologic Drug Registries to Assess Therapeutic Appropriateness- An Italian Regional Experience

    Nov 1, 2016, 00:00

  • Comparing Costs from a Pragmatic Randomised Trial to Published Modelling-Based Estimates- An Example from Prostate-Cancer Screening

    Nov 1, 2016, 00:00

  • Lenalidomide for Treating Multiple Myeloma After 1 Prior Treatment; An Application of Multi-State Markov Modelling for the Extrapolation of Patient Level Survival Data

    Nov 1, 2016, 00:00

  • Psychometric Evaluation of Clinical Outcomes Assessments in A Phase II Trial

    Nov 1, 2016, 00:00

  • How Much are Chinese Willing to Pay for the Health Improvement?

    Nov 1, 2016, 00:00

  • The Association Between Disability And Early Exit From Work In Osteoarthritis

    Nov 1, 2016, 00:00

  • Characteristics and Outcomes of Patients with Hospital-Acquired Pneumonia (Hap)

    Nov 1, 2016, 00:00

  • Dexhelpp - Aging Population- Routine Data Based Analyses Of Fractures Due To Falls Less Than Three Meters – Hospitalization, Readmission And Mortality

    Nov 1, 2016, 00:00

  • Projected Long-Term Outcomes in Patients with Type 1 Diabetes Mellitus Treated with Faster-Acting Insulin Aspart Versus Conventional Insulin Aspart in the UK Setting

    Nov 1, 2016, 00:00

  • Clinical And Economic Analysis Of Two Surfactants For The Prevention And Treatment Of Respiratory Distress Syndrome

    Nov 1, 2016, 00:00

  • Economic Burden of Colorectal Resections- Incremental Effects in Cancer Patients

    Nov 1, 2016, 00:00

  • Diagnostic Accuracy of Assessment Methods for Diagnosing Diabetic Peripheral Neuropathy (DPN)- A Systematic Review and Meta-Analysis- An Evidence Based Approach

    Nov 1, 2016, 00:00

  • Adapting Data Sources for Systematic Literature Review Retrieves Additional Data Relevant for Asian HTA

    Nov 1, 2016, 00:00

  • Implications of Introducing Patient Heterogeneity in Cost Effectiveness Modeling

    Nov 1, 2016, 00:00

  • Budget Impact of Continuous Subcutaneous Insulin Infusion Compared with Multiple Daily Insulin Injections for The Treatment of Type 1 Diabetes in Spain

    Nov 1, 2016, 00:00

  • Dose Extension and Costs of Lanreotide Autogel 120 Mg Used in Routine Neuroendocrine Tumors Care In Poland – 2- Years Data From Lanro-Net Study

    Nov 1, 2016, 00:00

  • Assessing Primary Care Practice Capacity For Quality Improvement- Preliminary Findings From Healthy Hearts in The Heartland (H3)

    Nov 1, 2016, 00:00

  • Situation and Impact of Insulin Pen Needle Reuse for Patients with Diabetes in China

    Nov 1, 2016, 00:00

  • Analysis of Cardiovascular Disease Burden on The Insured Population of Units Directly Under Fujian Province

    Nov 1, 2016, 00:00

  • Knowledge And Participation Rate on Cervical Cancer Screening Among Romany Minority Population

    Nov 1, 2016, 00:00

  • Equity of Government Subsidy in Health Care- A Case Study in China

    Nov 1, 2016, 00:00

  • Bayesian Network of Disease History

    Nov 1, 2016, 00:00

  • Assessing Quality Of Life Of Self-Reported Rheumatic Patients

    Nov 1, 2016, 00:00

  • Actuarial Approaches To Modelling and Mitigating Financial Uncertainty in Recommending New Drugs and Health Technologies

    Nov 1, 2016, 00:00

  • Project Octo-Pills- Management Of Polypharmacy And Drug Related Problems From Hospital To Community Pharmacies – An Octopus Initiative For The Silver Tsunami

    Nov 1, 2016, 00:00

  • An Exploration of Techniques for Addressing Uncertainty in Survival Estimates used Within Partitioned-Survival Models

    Nov 1, 2016, 00:00

  • Health Technology Assessment on Continuous And Intermittent Renal Replacement Therapies For Acute Kidney Injury In Adult Patients

    Nov 1, 2016, 00:00

  • Health-Economic Analysis of The Use of Sensor-Augmented Pump with Predictive Suspend Function (SAP) Therapy in Sweden Compared to Insulin Pump Therapy Alone (CSII), in Type 1 Diabetic Patients

    Nov 1, 2016, 00:00

  • Work and Income Loss Consideration Among Patients With Herpes Zoster When Completing A Quality Of Life Questionnaire

    Nov 1, 2016, 00:00

  • Universal Health Coverage in Countries Across East and Southeast Asia – Associations Between Health Expenditure and Service Provision

    Nov 1, 2016, 00:00

  • Cross-Validation of A 7-Item Clinical Decision Rule for Detecting Panic-Related Anxiety in Emergency Medicine Patients

    Nov 1, 2016, 00:00

  • Quality of Life of Stroke Survivors and Their Informal Caregivers- A Prospective Study

    Nov 1, 2016, 00:00

  • Single-Arm Trials in Systematic Reviews- Are They Adequately Captured by Existing Search Filters?

    Nov 1, 2016, 00:00

  • A CPRD-HES Database Study of Back Pain In The UK- Incidence And Prevalence

    Nov 1, 2016, 00:00

  • Eliciting Stated Preferences Regarding Life Extensions Near the End of Life- A Pilot Study for a Refinement of the Qaly

    Nov 1, 2016, 00:00

  • Economic Evaluation of Tiotropium/Olodaterol Administrated Through The Respimat Inhaler As Maintenance Treatment of Patients With Chronic Obstructive Pulmonary Disease (COPD) In Poland

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Dabigatran for The Prevention of Stroke in Iranian Atrial Fibrillation Patients

    Nov 1, 2016, 00:00

  • Preliminary Evaluation Of “Introducing Immigrants To The Healthcare System In Chile” Pilot Programme

    Nov 1, 2016, 00:00

  • Rosuvastatin- Switching Treatment and Clinical Implications in Primary Care

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Dapagliflozin Versus Glimepiride as Monotherapy in Patients with Type 2 Diabetes Mellitus in China

    Nov 1, 2016, 00:00

  • Estimating the Value of Treatment for Fabry Disease- A Discrete Choice Experiment

    Nov 1, 2016, 00:00

  • Real Time Patient Reported Outcomes Assessment in Routine Rheumatology Clinic - Feasibility Study of Myra Touch

    Nov 1, 2016, 00:00

  • Relationship between Insulin Adherence and Health Care Resource Utilization among Type 2 Diabetes Patients in China

    Nov 1, 2016, 00:00

  • Cost-Sharing In Healthcare- An Approach For Pharmaceutical Care In Greece

    Nov 1, 2016, 00:00

  • A Novel Method for Evaluating Value Assessment Frameworks

    Nov 1, 2016, 00:00

  • Assessment of Utility for Heart Failure using Visual Analogue Scale(VAS), Time-Trade off(TTO) and Euroqol-5 Dimension(EQ-5D) in the Korean General Population

    Nov 1, 2016, 00:00

  • Cost Effectiveness of Sacubitril/Valsartan Versus Angiotensin-Converting-Enzyme Inhibitor For The Treatment of Heart Failure From Public Health Perspective in Chile

    Nov 1, 2016, 00:00

  • Cost Effectiveness Analysis of Rivaroxaban For Treatment of Deep Vein Thrombosis And Pulmonary Embolism In Greece

    Nov 1, 2016, 00:00

  • Rate and Healthcare Utilization (Los And Costs) of Adhesion Related Complications after Liver Resection Surgery

    Nov 1, 2016, 00:00

  • Evaliation of Utility Index of Quality of Life In Hepatitis Patients in Japan

    Nov 1, 2016, 00:00

  • Treatment Patterns of Relapsed and Refractory Multiple Myeloma in Europe (EU-28)

    Nov 1, 2016, 00:00

  • Cost-Minimization Analysis of Laparoscopic and Open Surgery for Rectal Cancer

    Nov 1, 2016, 00:00

  • Comparing The EQ-5D-5L Value Sets Across Diferent Countries – Impact on Inpertretation of Clinical Study Results

    Nov 1, 2016, 00:00

  • Comparative Analysis of Clinical Trial Attributes in Pivotal Studies for Orphan vs. Non-Orphan Oncology Products FDA-Approved between 2011 and 2015

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis Of Highly Innovative Treatments For Hepatitis C- The Case Of Ledipasvir/Sofosbuvir In A Greek Healthcare Setting

    Nov 1, 2016, 00:00

  • Using Clinical Trial and Real World Data to Bridge Efficacy to Effectiveness of Fingolimod in Multiple Sclerosis Patients

    Nov 1, 2016, 00:00

  • Patient Reported Asthma Control In Comparison To Physician Assessed Asthma Control- A Cross-Sectional Analysis of The Act Questionnaire Based on 673 Asthma Patients

    Nov 1, 2016, 00:00

  • The Epidemiology and Cardiovascular Disease Risk Assessment of Patients Currently on Lipid Lowering Treatment with Statin- Nationwide Cross-Sectional Study in Korea

    Nov 1, 2016, 00:00

  • Time To Formal ‎Reimbursability ‎For Innovative ‎Drugs In Italy ‎

    Nov 1, 2016, 00:00

  • Complementary and Alternative Medicine use and Its Association with Quality of Life Among Cancer Patients Receiving Chemotherapy in Ethiopia- A Cross Sectional Study

    Nov 1, 2016, 00:00

  • Analysis of The Costs Associated with Vitamin K Antagonist Treatment for Stroke Prevention in Non Valvular Atrial Fibrialltion in Mexico

    Nov 1, 2016, 00:00

  • The Direct Cost-Components in Pulmonary Arterial Hypertension- An Expert Panel Approach for Estimation of Costs

    Nov 1, 2016, 00:00

  • Societal Impact of Pain (SIP) 2016 - 8 Policy Recommendations- Time for Action

    Nov 1, 2016, 00:00

  • Assessment of Knowledge of Urinary Tract Infection (UTI) Amongst School-Going Adolescent Girls

    Nov 1, 2016, 00:00

  • Beyond Cervical Cancer- The Cost-Effectiveness Of Hpv Vaccination In The Netherlands

    Nov 1, 2016, 00:00

  • Lost in Translation- Randomised Controlled Trial and Systematic Review Evidence of Intracoronary Versus Intravenous Abciximab in St-Elevation Myocardial Infarction

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of A Potential Treatment Introduction for Anorexia-Cachexia in Non-Small Cell Lung Cancer Patients

    Nov 1, 2016, 00:00

  • The Evaluation of Relationship between Regular Inspection and Committing Major Malpractice in Pakdasht Pharmacies

    Nov 1, 2016, 00:00

  • Validity Of The Eq-5d-Youth In Asthmatic Children

    Nov 1, 2016, 00:00

  • Quality of Life Measured with Eq-5d in Patients with Major Depressive Disorder in Japan

    Nov 1, 2016, 00:00

  • Good Enough For Policy Work? Study-Design Challenges In Implementing Stated-Preference Methods For Complex Health-Care Technologies

    Nov 1, 2016, 00:00

  • A Proposed Holistic Conceptual Framework for Barriers to Medication Adherence in Diabetes

    Nov 1, 2016, 00:00

  • A Comparison of National Guidelines for Network Meta Analysis

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Exenatide Once Weekly Versus Insulin Glargine and Liraglutide for the Treatment of Type 2 Diabetes in Greece

    Nov 1, 2016, 00:00

  • Herpes Zoster And Postherpetic Neuralgia- Quality Of Life And Healthcare Utilization, A German Study

    Nov 1, 2016, 00:00

  • A Cost Per Responder Analysis of Secukinumab Vs Adalimumab Based on A Matching-Adjusted Indirect Comparison For The Treatment of Ankylosing Spondylitis From A German Payer Perspective

    Nov 1, 2016, 00:00

  • A Real-World Outcome Research Study On Quality of Life, Work Productivity And Healthcare Resource Utilization In Metastatic Breast Cancer For Patients And Caregivers

    Nov 1, 2016, 00:00

  • Personalized Adaptive Rewards Versus Incentives to Motivate Sustainable Healthy Behavioral Change- A Neo-Maslowian Conceptual Model

    Nov 1, 2016, 00:00

  • Increasing Trend Of Health Related Quality Of Life Awareness For Diabetic Care Among Indian Scientists

    Nov 1, 2016, 00:00

  • Similarities and Differences of Risk Sharing Arrangements in Australia, United Kingdom, Italy, and Korea

    Nov 1, 2016, 00:00

  • Table of Contents

    Nov 1, 2016, 00:00

  • Racial Differences in Cardiovascular Disease in The United States- Healthcare Resource Utilization and Costs

    Nov 1, 2016, 00:00

  • Identifying the Key Parameters of the European-Study on Quantifying Utility of Investment in Protection from Tobacco (EQUIPT) Model

    Nov 1, 2016, 00:00

  • Alemtuzumab Budget Impact For Multiple Sclerosis Treatment In Spain

    Nov 1, 2016, 00:00

  • "Why Can't I Just Use Google Translate?" A Study on the Effectiveness of Online Translation Tools in Translation of Coas

    Nov 1, 2016, 00:00

  • Discordance Between Knowledge of Cardiovascular Risk Factors and Ideal Cardiovascular Health in Hong Kong Adults

    Nov 1, 2016, 00:00

  • Incorporating Biometric Data from Wearable Activity Trackers with Study Data in France and the UK

    Nov 1, 2016, 00:00

  • Budget Impact Model Of Indacaterol/Glycopyrronium In The Treatment Of Copd In Italy Based On Flame Study

    Nov 1, 2016, 00:00

  • Budget Impact Analysis of Sacubitril/Valsartan Versus Angiotensin-Converting-Enzyme Inhibitor for The Treatment of Heart Failure From Public Health Perspective in Chile

    Nov 1, 2016, 00:00

  • Economic Burden of Hospitalization for Hepatic Encephalopathy in Fran An Analysis of Cost Discriminating Factors By Patient Profile

    Nov 1, 2016, 00:00

  • Innovative Approach To Keeping Evidence Current And Guidelines Living

    Nov 1, 2016, 00:00

  • A Value for Money Threshold for New Technologies for Very Rare Diseases- Does the Nice Highly Specialised Committee Employ One?

    Nov 1, 2016, 00:00

  • Systematic Review And Meta-Analysis of Accuracy of Diagnostic Tests For Screen Detection of Atrial Fibrillation

    Nov 1, 2016, 00:00

  • Acute Respiratory Distress Syndrome Profile at a Tertiary Care Teaching Hospital in South India

    Nov 1, 2016, 00:00

  • Comparison Between Cancer Drugs Assessment In Portugal And United Kingdom

    Nov 1, 2016, 00:00

  • Use of Nimotuzumab in The Treatment of Locally Advanced Esophageal Cancer in Real World

    Nov 1, 2016, 00:00

  • Comparative Effectiveness of Crizotinib Among ALK+ NSCLC Patients Across The United States, Western Europe, and Japan

    Nov 1, 2016, 00:00

  • Prescription Patterns and Drugs Costs in Patients with Dementia - A Retrsopective Database Analysis

    Nov 1, 2016, 00:00

  • How time and severity increases the overall cost and resource utilization of patient with severe liver disease. Main burdens and consequences to health system

    Nov 1, 2016, 00:00

  • Cost Analysis of Different Sequential Treatment Regimens for Metastatic Renal Cell Carcinoma in China

    Nov 1, 2016, 00:00

  • Systematic Review and Meta-Analysis of Risperidone for the Treatment of Schizophrenia

    Nov 1, 2016, 00:00

  • Metastatic Colorectal Cancer- The Burden of Illness in The Uk and Ireland

    Nov 1, 2016, 00:00

  • Clinical and Economic Analysis of Eyelid Hygiene Complex for Patients with Meibomian Glands Dysfunction in Russia

    Nov 1, 2016, 00:00

  • What is Government's Responsibility for China's Universal Health Security? An Outlook for a National Health Security System

    Nov 1, 2016, 00:00

  • Cost-Utility Evaluation of Insulin Glargine 300 (GLA-300) Versus Insulin Glargine 100 (GLA-100) in Patients with Type 2 Diabetes Mellitus (T2DM)

    Nov 1, 2016, 00:00

  • Pharmacoeconomics Analysis of ACEI and ARB Against Essential Hypertension- A Case Study of Shanghai

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of A Bone Transplant Fixation “Shark Screw” Transplant Compared To Metal Devices In Oesteosynthesis In Austria

    Nov 1, 2016, 00:00

  • Mcda Application In Central And Eastern Europe- Selection Of The Most Important Criteria Based On Examples

    Nov 1, 2016, 00:00

  • Investigating the Implementation of Adverse Events in Economic Models- A Systematic Literature Review in Multiple Sclerosis and Human Immunodeficiency Virus

    Nov 1, 2016, 00:00

  • Economic Impact of Olaparib in Patients with Platinum Sensitive Relapsed Brca Mutated Epithelial Ovarian Cancer in Spain

    Nov 1, 2016, 00:00

  • Cost of Treatment of Pancreas Transplantation Therapy and Insulin Pump Therapy of Type I Diabetes Mellitus

    Nov 1, 2016, 00:00

  • Sampling of Commonly used Population Characteristics- Is A Normal Approximation Valid?

    Nov 1, 2016, 00:00

  • Differences in Cost-Effectiveness Estimates for Chronic Hepatitis C Treatment Among Cohort Markov Model, Markov Microsimulation and Discrete Event Simulation

    Nov 1, 2016, 00:00

  • Costs And Outcomes Of Hospital Infections In Italy

    Nov 1, 2016, 00:00

  • Budget Impact Analysis of Xydalba from the Perspective of Italian National Health System

    Nov 1, 2016, 00:00

  • Food for Thought (But Not Too Much) for Health Economic Analyes of Nutritional Interventions in Obesity

    Nov 1, 2016, 00:00

  • Big Data In Healthcare - Opportunities And Challenges

    Nov 1, 2016, 00:00

  • Does Real World Evidence Support Conclusions From Experimental Evidence In Decision-Making Processes In Poland?

    Nov 1, 2016, 00:00

  • Methods for Time-Varying Exposure – A Literature Review

    Nov 1, 2016, 00:00

  • Implementation of Conditional Reimbursement Schemes in HTA Practi Experiences from the Netherlands

    Nov 1, 2016, 00:00

  • Evaluation of The Cost Saving Potential of Introducing An Etanercept Biosimilar (Benepali®) For The Treatment of All Licensed Adult Etanercept Indications In The UK

    Nov 1, 2016, 00:00

  • Methods For The Design And Conduct Of Medical Record Reviews In Oncology

    Nov 1, 2016, 00:00

  • Valuing Cancer-Related Premature Mortality- A Comparison of Consumer-Led Versus Producer-Led Approaches

    Nov 1, 2016, 00:00

  • Health-Related Quality of Life In Patients with Systemic Lupus Erythematosus (SLE)- A Spanish Study Based on Patient Reports

    Nov 1, 2016, 00:00

  • Epidemiology and Costs of Psoriatic Arthritis in Germany – A Retrospective Claims Data Analysis

    Nov 1, 2016, 00:00

  • Recommendations In Clinical Guidelines, ‘No Benefit’ Ratings, And Opt-Out Decisions In Germany Since The Introduction Of The Amnog Law In 2011- How Do The Pieces Fit Together?

    Nov 1, 2016, 00:00

  • Measuring Income-Related Inequity In Self-Assessed Health Using The EQ-5D In 7 Countries

    Nov 1, 2016, 00:00

  • Three-Monthly Long-Acting Formulation of Paliperidone Palmitate is a Dominant Treatment Option, Cost Saving While Adding Qalys, Compared to the One-Monthly Formulation in the Treatment of Schizophrenia in France

    Nov 1, 2016, 00:00

  • Reducing Medical Claims Cost to Ghana’s National Health Insurance Scheme- Paper-Based Versus Electronic-Based Claims Review

    Nov 1, 2016, 00:00

  • Synthesis of Binary Outcome Data on the Log-Odds and Absolute Risk Scales – A Case Study in Chronic Hepatitis C

    Nov 1, 2016, 00:00

  • Cost Effectiveness Evaluation of Fracture Liaison Services for the Management of Osteoporosis in Sweden

    Nov 1, 2016, 00:00

  • Estimation of The Direct Cost of COPD In Bulgaria

    Nov 1, 2016, 00:00

  • Effects of Opioid use with and without Over-The-Counter Analgesics on Economic Outcomes Among Adults with Pain in the United States

    Nov 1, 2016, 00:00

  • Risk Elements and Drug Utilization in Stroke Patients

    Nov 1, 2016, 00:00

  • Cost Of Dengue And Cost-Effectiveness Of The Dengue Vaccine In Panama

    Nov 1, 2016, 00:00

  • The Structure and Vascularization of Choroid Plexus of Brain in Children Aged From 0–3 Years Old

    Nov 1, 2016, 00:00

  • Economic Analysis of Endovascular Interventions for The Treatment of Femoropopliteal Peripheral Artery Disease in Austria

    Nov 1, 2016, 00:00

  • Outcomes for Older Patients with Acute Myeloid Leukemia (AML)- Multiple Hospitalizations and High Mortality Rates

    Nov 1, 2016, 00:00

  • A Cohort Study to Access the Impact of Paediatric Use of Proton Pomp Inhibitor on the Risk of Community Acquired Infections €“ Utopie

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Newer Antiepileptic Drugs (Aeds) For Management of Partial Epilepsy In Children In Malaysia

    Nov 1, 2016, 00:00

  • A General Model for The Estimation of Societal Costs of Lost Production and Informal Care In Italy

    Nov 1, 2016, 00:00

  • Comorbidites and Patient-Reported Outcome after Total Hip Arthroplasty

    Nov 1, 2016, 00:00

  • Budget Impact Analysis Of Including A Pentavalent (Hib-Hbv-Dtp) Vaccine In The National Childhood Immunization Schedule Of Iran

    Nov 1, 2016, 00:00

  • The Apheresis- Database (APHDA)-Project- Patient Characteristics Treatment Patterns of Apheresis Patients in Germany

    Nov 1, 2016, 00:00

  • The Quality of Pharmacoeconomic Publications in Breast Cancer Pharmacotherapies in China

    Nov 1, 2016, 00:00

  • Clinical Trials Scenario In Brazil- Study And Sponsor Profiles

    Nov 1, 2016, 00:00

  • Quantifying the Health Economic Value Associated with Unit Changes in HBA1C in Type 1 Diabetes Mellitus

    Nov 1, 2016, 00:00

  • Is the Lack of Inclusion on the National Drug Reimbursement List the end of the World for Access?

    Nov 1, 2016, 00:00

  • Regulatory Agencies Perspective on Progression-Free-Survival (PFS)

    Nov 1, 2016, 00:00

  • Implementation Of The Insurance Programs For Catastrophic Diseases In China- A Qualitative Study

    Nov 1, 2016, 00:00

  • Kangaroo Mother Care- A Cost Effective and an Alternate Method to Manage Hypothermia in Low Birth Weight Babies for Better Clinical Outcome

    Nov 1, 2016, 00:00

  • Flexibly Modelling HBA1C Progression in Type 2 Diabetes to Estimate the Impact of Clinical Inertia on Costs and Quality Adjusted Life Years

    Nov 1, 2016, 00:00

  • Impact of Poverty on Health Care Utilization in the Elderly

    Nov 1, 2016, 00:00

  • Direct Costs and Healthcare Resource Use Associated with Advanced Non-Small Cell Lung Cancer Management in Previously Treated Patients in Portugal

    Nov 1, 2016, 00:00

  • The Uk Early Access To Medicines Scheme- A 2-Year Status Update On Successes, Issues And Controversies

    Nov 1, 2016, 00:00

  • Patterns of Care Among Pancreatic Cancer Patients- Findings from a u.s. Real-world claims-based analysis

    Nov 1, 2016, 00:00

  • Management of Metastatic Colorectal Cancer Patients- A Methodological Approach to Identify Treatment Lines

    Nov 1, 2016, 00:00

  • A Population Based Diabetes Drug Utilization Analysis in Chinese Community- A Retrospective Database Study

    Nov 1, 2016, 00:00

  • Construct Validity Of The 10-Year Time Trade-Off Method In Psoriasis Patients

    Nov 1, 2016, 00:00

  • Cost Minimization Analysis of Generic Versus Brand Form of Deferasiroix N The Management of B-Thalassemia Patients with Chronic Iron Overload- An Egyptian Health Care Provider Perspective

    Nov 1, 2016, 00:00

  • Extrapolation with Patient Level Time-To-Event Data in Various Disease Areas- A Review of Current Recommendations and Gaps

    Nov 1, 2016, 00:00

  • Racial/Ethnic Disparity in Individual Economic Burden of Diabetes in the USA

    Nov 1, 2016, 00:00

  • Evaluation of the Effect of Pharmacogenetic Dosing of Warfarin- Should Non-Randomized Clinical Studies be Considered?

    Nov 1, 2016, 00:00

  • Cost-Utility Analysis of Neoadjuvant Chemotherapy with Pertuzumab, Trastuzumab and Docetaxel in Patients With HER2+ Breast Cancer in Spaincost-Utility Analysis of Neoadjuvant Chemotherapy with Pertuzumab, Trastuzumab and Docetaxel in Patien ...

    Nov 1, 2016, 00:00

  • The Economic Burden of Hypertension in Latin America

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Adding Bedaquiline To Background Drug Regimens For The Treatment of Multidrug-Resistant And Extensively-Resistant Tuberculosis In Italy

    Nov 1, 2016, 00:00

  • Medication Safety Warnings- Awareness, Source and Actions of Consumers in the U.S

    Nov 1, 2016, 00:00

  • Quantifying Informal Versus Formal Care, and Financial Caregiver Burden, for Stroke Patients in Asia- A Structured Literature Review

    Nov 1, 2016, 00:00

  • The Societal and Humanistic Burden of Small Cell Lung Cancer (SCLC)- A Systematic Review of Societal Impact and Health-Related Quality Of Life (HRQOL) Literature

    Nov 1, 2016, 00:00

  • Burden of Non-Tuberculous Mycobacterial Pulmonary Disease In Germany Based on Sick Fund Data Analysis

    Nov 1, 2016, 00:00

  • Impact Of Patients Counselling On Mindful Attention Awareness And Stress In Cancer Patients

    Nov 1, 2016, 00:00

  • The Impress (International Multiple Sclerosis) Study; Results On The Socio-Economic Burden, Health Related Quality Of Life And Experience Of Multiple Sclerosis Patients In France

    Nov 1, 2016, 00:00

  • A Conceptual Framework of Baseline Equity for Rural Basic Medical Insurance in China- Based on Policy Process Theory

    Nov 1, 2016, 00:00

  • Certolizumab Pegol is Associated with Long-Term Improvements in Patient-Reported Outcomes in Axial Spondyloarthritis Patients, Including Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis- 4-Year Outcomes from the Rapid-Axs ...

    Nov 1, 2016, 00:00

  • Assessing Real Consumption of Medications for Fertility Treatments in Ukraine

    Nov 1, 2016, 00:00

  • Improving the System of Healthcare Provision for Patients with Diffuse Toxic Goiter in Ukraine

    Nov 1, 2016, 00:00

  • The Dynamics of Quality of Life In Children With Uncontrolled Severe Persistent Asthma

    Nov 1, 2016, 00:00

  • Geographic, Racial, and Temporal Variations of Adherence to Screening for Cervical Cancer and HPV Vaccination in The United States, 2008-2012

    Nov 1, 2016, 00:00

  • Cost Minimization Of 10% Intravenous Immunoglobulin Against Other Intravenous Immunoglobulin For Treating Primary Inmunodeficiencies

    Nov 1, 2016, 00:00

  • The Economic Evaluation of Bone-Anchored Hearing AIDS (BAHAS)- A Systematic Literature Review

    Nov 1, 2016, 00:00

  • Potential Factors Predicting The Response in The Treatment of Attention-Deficit/Hyperactivity Disorder Children with Atomoxetine in Asia Pacific Region

    Nov 1, 2016, 00:00

  • The Assessment of Value for Medical Devices- Using Real World Evidence (RWE) to Quantify Unmet Needs in Diabetes Management

    Nov 1, 2016, 00:00

  • Costs of Adverse Events Associated with Cancer Therapies in Non-Small Cell Lung Cancer in France

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Radial Access Versus Femoral for Diagnostic Cardiac Catheterization and Coronary Intervention in Colombia

    Nov 1, 2016, 00:00

  • Adverse Drug Reactions of Radiographic Contrast Media Used in Computed Tomography and Magnetic Resonance Imaging in India

    Nov 1, 2016, 00:00

  • Is There a Justification to Fullfill the Gap in Clinical Pathway of Inflammation and Itching Treatment in Poland - Cost-Utility Analysis (CUA) of Mometasone Furoate Ointment

    Nov 1, 2016, 00:00

  • The Management and Costs of Multiple Myeloma in Gree Mapping the Local Treatment Pathway and Associated Resource Use

    Nov 1, 2016, 00:00

  • Differences In Pricing Policies For Generic And Biosimilar Medicines

    Nov 1, 2016, 00:00

  • The Quev Score- A Quantitative Evaluation of the Quality of Clinical Evidence in HTA

    Nov 1, 2016, 00:00

  • The Short-Term Health and Economic Burden of Gestational Diabetes Mellitus in Italy

    Nov 1, 2016, 00:00

  • Comparisons of Treatment Patterns for Type 2 Diabetes Mellitus (T2DMm) in Japan and in the United States

    Nov 1, 2016, 00:00

  • Cost-Minimization Analysis of Panitumumab Vs Cetuximab as Monotherapy for Chemo-Refractory Patients with WT KRAS MCRC in Mexico

    Nov 1, 2016, 00:00

  • Analysis on the Utilization Status of Essential Medicines in Beijing's Community Health Institutions

    Nov 1, 2016, 00:00

  • A Network Meta-Analysis of Atomoxetine, Methylphenidate, Lisdexamfetamine, and Bupropion for the Treatment of Attention Deficit Hyperactivity Disorder in Children and Adolescents

    Nov 1, 2016, 00:00

  • Integration Of Basic Attention To The Specialized Attention Network In Brazil’s Health System

    Nov 1, 2016, 00:00

  • Extracting Dosage Per Day From Free-Text Medication Prescriptions

    Nov 1, 2016, 00:00

  • Trends of Including Pharmacoeconomics Course in the Undergraduate Pharmacy Curriculum

    Nov 1, 2016, 00:00

  • Reliability and Validity of the Health Assessment Questionnaire (Haq) in Patients with Spondyloarthritis

    Nov 1, 2016, 00:00

  • External Validity at Stake in Mapping Non-Preference Based Disease Specific Measures to Generic Preference-Based Utility Values in Advanced Cutaneous Melanoma

    Nov 1, 2016, 00:00

  • The Incidence of Hypoglycemia in Type II Diabetes Mellitus (T2DM) Patients Treated with Insulin Therapy in Combination with DPP-4 in Greece. A Sub-Analysis of Hypo 2 Study

    Nov 1, 2016, 00:00

  • Antibiotic Treatment of Uncomplicated Urinary Tract Infection In Women- A Comparative Cost-Effectiveness Study

    Nov 1, 2016, 00:00

  • Management and Outcomes of Acute Kidney Injury

    Nov 1, 2016, 00:00

  • A Health Technology Assessment of Single Balloon Valvuplasty

    Nov 1, 2016, 00:00

  • Economic Assessment of Dydrogesterone Compared with Progesterone for the Treatment of Threatened Andhabitual Miscarriage in China

    Nov 1, 2016, 00:00

  • Generating Health Utility Values From US SF-36 Scores For French Assessment- Comparison of 3 Mapping Methods

    Nov 1, 2016, 00:00

  • Health Status in Patients with Severe Haemophilia a According to Treatment Regimen and Age

    Nov 1, 2016, 00:00

  • Budget Impact Analysis Of Secukinumab In Moderate To Severe Plaque Psoriaris, Ankylosing Spondylitis And Psoriatic Arthritis In France

    Nov 1, 2016, 00:00

  • Direct Medical Costs Associaed with Diabetic Complicaitons in Patients with Type 2 Diabetes in Us and South Korea

    Nov 1, 2016, 00:00

  • Risk Share Agreements (RSA), Product Listing Agreements (PLA) or Patient Access Schemes (PAS) - All the Same or Different?

    Nov 1, 2016, 00:00

  • Long-Term Visual Functioning Improvement is Associated with Resolution of Vitreomacular Adhesion in Subjects with Vitreomacular Traction, Including Macular Hole Treated with Intravitreal Ocriplasmin- Results From The Oasis Study

    Nov 1, 2016, 00:00

  • Safety And Effectiveness of Autologous Platelet Rich Plasma Therapy For Lateral Epicondylitis- Systematic Reviews

    Nov 1, 2016, 00:00

  • Day Surgery Vs Regular Admission- Activity-Based Cost Analysis of Percutaneous Transluminal Coronary Angioplasty (PTCA) Procedures From Hospital Perspective

    Nov 1, 2016, 00:00

  • The Public Acceptance And Willingness-To-Pay (Wtp) Of Dengue Vaccine In Penang, Malaysia- Assessment with A Contingent Valuation Study

    Nov 1, 2016, 00:00

  • Availability And Costs Of Pediatric Formulations In India - A Case Study

    Nov 1, 2016, 00:00

  • Patient Focused Technology Enabled Programs Improve Outcomes in Primary Total Hip (THA) Total Knee Arthroplasty (TKA) Patients

    Nov 1, 2016, 00:00

  • Utility By Treatment Line In Multiple Myeloma; Analysis of Over 9000 EQ-5Q-3L Questionnaires from the Emmos Registry

    Nov 1, 2016, 00:00

  • Methodological Review of Survival Models- Application to A Persistence Analysis Based on Long Acting Parenteral Antipsychotic in Retail Pharmacies in France

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Screening for Severe Sleep-Disordered Breathing in Japan

    Nov 1, 2016, 00:00

  • Disease Burden of Herpes Zoster in Taiwan- A Five-Year Population-Based Study

    Nov 1, 2016, 00:00

  • The Case For Bayesian Methods In Benefit-Risk Assessment- Overview And Future Directions

    Nov 1, 2016, 00:00

  • Antibiotic Utilisation and Expenditure in Ireland

    Nov 1, 2016, 00:00

  • Cost-Related Medication Nonadherence Among Elderly Medicare Cancer Survivors Using Erythropoiesis-Stimulating Agents

    Nov 1, 2016, 00:00

  • Access To Anti-Infective Medicines For Systemic Use In Armenia

    Nov 1, 2016, 00:00

  • Estimation of Willingness to Pay for a Quality-Adjusted Life Year on a Cure

    Nov 1, 2016, 00:00

  • Cost of Antihyperglycemic Therapy In Type 2 Diabetes Patients Depending on HBA1C And Bmi Values

    Nov 1, 2016, 00:00

  • Cost-Efficiency Of Clinical Pharmacy Services At Ministry Of Health In Saudi Arabia Application Of American Model

    Nov 1, 2016, 00:00

  • Productivity Loss of Rheumatoid Arthritis Patients By Their Level Of Disease Activity Score

    Nov 1, 2016, 00:00

  • Trends In Outpatient Use Of Antibiotics In Croatia

    Nov 1, 2016, 00:00

  • How Well is Warfarin Controlled In Real World Clinical Practice in Hong Kong?

    Nov 1, 2016, 00:00

  • Use Of Electronic Health Information Systems (Ehis) By Healthcare Professionals (Hcps) And The Perception Of Its Value In Reducing Medication Risks And Safety For Patients

    Nov 1, 2016, 00:00

  • Knowledge of Blood Pressure Control Programs In University Students

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Ixekizumab vs. Secukinumab in Sequential Biologic Treatment of Psoriasis in the UK

    Nov 1, 2016, 00:00

  • Resource use in Chronic Heart Failure in the UK- A Systematic Review

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Of Incobotulinumtoxin-A With Flexible Treatment Intervals Compared To Fixed Treatment Intervals In The Management Of Blepharospasm And Cervical Dystonia

    Nov 1, 2016, 00:00

  • The Real-Life Effectiveness and Care Patterns of Diabetes Management Study for Greece. “RECAP-DM”

    Nov 1, 2016, 00:00

  • Quality Of Life and Economic Impact Of Neuropathic Pain and Fibromyalgia Syndrome In Chronic Back Pain Patients In Tertiary Care

    Nov 1, 2016, 00:00

  • Knowledge, Attitude and Practice Towards Hepatitis B Among Medical College Students of Quetta, Pakistan

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Long Acting Granulocyte Colony–Stimulating Factor for Primary Prophylaxis of Febrile Neutropenia in Breast Cancer in The Russia

    Nov 1, 2016, 00:00

  • Frequency of Occurance of Myocardial Infarction in Hungary Between 2004-2012

    Nov 1, 2016, 00:00

  • Analysis of The Costs Associated with Vitamin K Antagonist Treatment for Stroke Prevention in Non Valvular Atrial Fibrialltion in Russia

    Nov 1, 2016, 00:00

  • Absence of Price-Prevalence Correlation in Orphan Drugs in Italy

    Nov 1, 2016, 00:00

  • How are Adverse Effects Incorporated in Cost-Effectiveness Models? A Study of Current Practice in Oncology Studies Submitted to HAS

    Nov 1, 2016, 00:00

  • Economic Evaluation of Targeted Therapies in Metastatic Clear Renal Cell Carcinoma in Canada

    Nov 1, 2016, 00:00

  • Evaluation of Quality of Pharmacoeconomic Studies in Asia Pacific and Identification of Influencing Variables

    Nov 1, 2016, 00:00

  • Reflecting Uncertainty in Early HTA When Evidence on Parameter Distributions is Lacking- A Comparison of Methods

    Nov 1, 2016, 00:00

  • Systematic Review of the Value of Safety-Engineered Devices in Reducing Needlestick and Sharps Injuries

    Nov 1, 2016, 00:00

  • Is utilization of Adjuvant Endocrine Therapy Affected Mainly by Patient Drug Costs? An Analysis of Two Databases

    Nov 1, 2016, 00:00

  • Annual Cost Аnalysis for Medicinal Products for Rare Diseases in Bulgaria

    Nov 1, 2016, 00:00

  • Australian Influenza National Surveillance Data (2009 to 2014) – Variations by Sex, Age Group, and Influenza Type

    Nov 1, 2016, 00:00

  • Pharmacoeconomic Assessment of Nintedanib For The Treatment of Idiopathic Pulmonary Fibrosis In The Greek Healthcare System

    Nov 1, 2016, 00:00

  • Manufacturers’ And Pharmacists’ Satisfaction with Different Pharmaceutical Distribution Models in Europe

    Nov 1, 2016, 00:00

  • Rare and Intractable Disease Policy Reform in Japan- A Before and After Analysis

    Nov 1, 2016, 00:00

  • Safety and Efficacy of High-Potency Statin and Ultra-Low LDL in Chinese Patients with Established Cardiovascular Disease- Practice Impact of the New Cholesterol Guidelines

    Nov 1, 2016, 00:00

  • Social And Economic Value of Portuguese Community Pharmacies In Public Health

    Nov 1, 2016, 00:00

  • Non-Adherence to Antihypertensive Drugs- A Systematic Review and Meta-Analysis

    Nov 1, 2016, 00:00

  • Optimal Design of Pre-Authorization Trials for Effectiveness Evaluation in Severe Asthma

    Nov 1, 2016, 00:00

  • The EQ-5D-5L Instrument Demontrates Better Performance Compared With The EQ-5D-3L In Psoriatic Patients

    Nov 1, 2016, 00:00

  • Evaluating the Cost-Effectiveness of Liraglutide 1.8Mg Versus Lixisenatide 20μg for Patients with Type 2 Diabetes Mellitus in the UK Setting

    Nov 1, 2016, 00:00

  • Identification of Adverse Events In Coronary Artery Disease Patients Based on Health-Related Quality of Life Outcome Data

    Nov 1, 2016, 00:00

  • Swedish Perspective on Health Technology Assessments with Incrementally Lower Costs and Effects

    Nov 1, 2016, 00:00

  • A Review of Health State Utility Values Used in UK Nice Appraisals in Advanced NSCLC

    Nov 1, 2016, 00:00

  • A Risk-Benefit Analysis of Key Performance-Based Risk Sharing Agreements (PBRSAS) in the EU and US (2002-2016)

    Nov 1, 2016, 00:00

  • Utilization Of Physiotherapy Visits Completed In Specialized Home Care In Hungary Between 2010 And 2014

    Nov 1, 2016, 00:00

  • Impact of Hypoglycaemic Events on Healthcare Resource Use in Type 2 Diabetes Patients

    Nov 1, 2016, 00:00

  • The Relationship Between Antenatal Care And Health Facility Delivery

    Nov 1, 2016, 00:00

  • The Increasing Role of Wearable Digital Technology in Disease Management - An Assessment of the Opportunities and Challenges from a Multi-Stakeholder (Patient, Payer, Physician, Manufacturer) Perspective

    Nov 1, 2016, 00:00

  • Economic Modeling of Risk-Adapted Screen-and-Treat Strategies in Women at High-Risk for Breast or Ovarian Cancer

    Nov 1, 2016, 00:00

  • Clinical and Economic Impact of Blood Cultures Among Adult Patients Admitted with Pneumonia in Tianjin, China

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of An Automated Medication System Implemented In A Danish Hospital Setting

    Nov 1, 2016, 00:00

  • Clinical Effectiveness of Ranibizumab And Aflibercept For Central RVO- A Retrospective Cohort Study Using Electronic Medical Records From The USA

    Nov 1, 2016, 00:00

  • Accounting for the Imperfect External Validity of Discrete Choice Experiments When Predicting Demand

    Nov 1, 2016, 00:00

  • The Burden of Illness of Mycosis Fungoides Cutaneous T-Cell Lymphoma- A Retrospective Cohort Study of a Commercially Insured Population in the U.S

    Nov 1, 2016, 00:00

  • The Effect of Physical Activity on the Mental and Emotional State of University Students

    Nov 1, 2016, 00:00

  • Comparison of Three Generic Utility Instruments In Patients With Renal Disease

    Nov 1, 2016, 00:00

  • The Direct Cost Components in Heart Failure with Preserved Ejection Fraction (HF-PEF) in Turkey- The Results of A Delphi Panel

    Nov 1, 2016, 00:00

  • Extra Budgetary Reimbursement Options For Innovations In The German Hospital Sector

    Nov 1, 2016, 00:00

  • Unlocking Established Products Patient and Societal Value in Additional Indications

    Nov 1, 2016, 00:00

  • Economic considerations on the use of recombinant vs. Plasmatic factor VIII in the treatment of previously untreated haemophilia a patients

    Nov 1, 2016, 00:00

  • Economic Evaluation Of Abbvie’s Regimen (Viekirax/Exviera) For Patients With Genotype 1b Hcv In Greece

    Nov 1, 2016, 00:00

  • Mathematical Model to Synthesize Natural History of Tick Borne Encephalitis and Lyme Borreliosis for the Purpose of Cost-Effectiveness Analysis

    Nov 1, 2016, 00:00

  • Modelling the Effectiveness of Ibrutinib Versus Rituximab-Based Chemotherapy Regimens in Relapsed/Refractory Mantle Cell Lymphoma

    Nov 1, 2016, 00:00

  • Racial Disparities In Access To Pharmacy And Its Services In Pennsylvania

    Nov 1, 2016, 00:00

  • Feasibility of Electronic Medical Records in Australia, China, and Japan to Support Novelty (A Novel Observational Longitudinal Study of Patients with Asthma and/or COPD)

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Nivolumab vs. Docetaxel as Second-Line Treatment for Advanced Non-Small Cell Lung Cancer

    Nov 1, 2016, 00:00

  • Quality of Life of Patients Treated for Multiple Myeloma (MM) in France in a Real-World Setting

    Nov 1, 2016, 00:00

  • The Relationship Between Target Joints And Non-Drug Direct Costs In Severe Haemophilia

    Nov 1, 2016, 00:00

  • Somatic Symptoms in Patients with Undiagnosed Depression- Prevalence and Health Care Utilization In Japan

    Nov 1, 2016, 00:00

  • Antimicrobial Agents Dispensing In Upper Respiratory Tract, Gastrointestinal Tract Infections And Infected Wound In Thai Drug Stores In 2015

    Nov 1, 2016, 00:00

  • The Burden of Comorbid Allergic Rhinitis and Asthma

    Nov 1, 2016, 00:00

  • A 12-Week Cost Analysis to Compare Fluticasone Furoate/Vilanterol And Beclomethasone Dipropionate/Formoterol In The Treatment of Mild-To-Moderate Asthma

    Nov 1, 2016, 00:00

  • Estimating the Value of A New Antibiotic- A Novel Approach Using Esbl As A Case Study

    Nov 1, 2016, 00:00
  • «
  • 71 (current)
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • »